Jazz Pharmaceuticals plc (JAZZ) NASDAQ

131.16

-2.89(-2.16%)

Updated at November 07 04:00PM

Currency In USD

Valuation

Market Cap7.62B
Enterprise Value11.36B
P/E Ratio-21.6
PEG Ratio-2.23
Price/Sales Ratio1.92
Price/Book Ratio2.01
Enterprise/Revenue1.86
Enterprise/EBITDA30

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.09
Operating Margin-0.12

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.09

Income Statement

Revenue4.07B
Revenue/Share68.5
Gross Profit3.62B
EBITDA1.52B
Net Income560.12M
Diluted EPS8.65

Balance Sheet

Total Cash1.33B
Total Cash/Share21.85
Total Debt1.08B
Total Debt/Equity0.27
Current Ratio1.65
Book Value Per Share65.23

Price History

52-Week Change6.11
52-Week High148.06
52-Week Low95.49
Moving Average 50 Days133.21
Moving Average 200 Days121.79

Statistics

Average Volume710,595
Shares Outstanding60.76M
% Held by Institutions96.33

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A